Cargando…
In-silico immunoinformatic analysis of SARS-CoV-2 virus for the development of putative vaccine construct
COVID-19 (CoronaVirus disease 2019) is caused by the SARS-CoV-2 virus (severe acute respiratory syndrome corona virus 2). SARS-CoV-2 virus is highly contagious and affects the human respiratory tract resulting in symptoms such as high fever, body ache, cough, dysfunctions of tastebuds and smelling s...
Autores principales: | Sharma, Abhishek, Pal, Surinder, Panwar, Anil, Kumar, Suresh, Kumar, Ashok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier GmbH.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404695/ https://www.ncbi.nlm.nih.gov/pubmed/34474252 http://dx.doi.org/10.1016/j.imbio.2021.152134 |
Ejemplares similares
-
In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools
por: Antonelli, Ana Clara Barbosa, et al.
Publicado: (2022) -
Identification of vaccine candidate against Omicron variant of SARS-CoV-2 using immunoinformatic approaches
por: Aasim, et al.
Publicado: (2022) -
Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication
por: Kumar, Suresh, et al.
Publicado: (2021) -
Structure-based drug designing and immunoinformatics approach for SARS-CoV-2
por: Panda, Pritam Kumar, et al.
Publicado: (2020) -
Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework
por: Kumar, Neeraj, et al.
Publicado: (2021)